STOCK TITAN

Amrize Ltd (AMRZ) SEC Filings, Jun-Aug 2025

AMRZ NYSE

Welcome to our dedicated page for Amrize SEC filings (Ticker: AMRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Amrize Ltd filings document a Swiss-incorporated North American building-solutions company with ordinary shares listed on the New York Stock Exchange and SIX Swiss Exchange. The company’s SEC reports include Form 8-K disclosures for quarterly and annual financial results, Regulation FD investor materials, dividend-related events, auditor changes, and board or executive appointments.

Proxy and annual meeting filings cover shareholder voting, board elections, compensation matters, distributions from legal reserves from capital contributions, and governance procedures under the company’s Swiss corporate structure. The filing record also documents Amrize’s completed spin-off from Holcim and related public-company reporting matters.

Rhea-AI Summary

Denise R. Singleton, listed as Chief Legal Officer & Corp Sec of Amrize Ltd (AMRZ), filed a Form 4 reporting a change in beneficial ownership on 08/08/2025. The filing shows 4,000 ordinary shares associated with a transaction code “P” and a price of $47.64. The Form 4 was signed by Hans Weinburger as attorney-in-fact on 08/11/2025. The filing lists the reporting person as an officer and was filed by one reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ian A. Johnston, identified as Chief Financial Officer, executed multiple purchases totaling 10,500 ordinary shares of Amrize Ltd on 08/08/2025 at prices between $47.66 and $47.75 per share. The reported transactions raised his beneficial ownership to 17,344 ordinary shares. The Form 4 lists only non-derivative purchases in separate lots and shows no derivative holdings reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UBS Group AG, through its UBS Asset Management division, reports beneficial ownership of 38,197,652 ordinary shares of Amrize Ltd, representing 6.74% of the class. UBS Asset Management reports sole voting power over 35,252,775 shares and shared dispositive power over 38,197,652 shares, indicating voting control for most of its reported position.

The filing identifies UBS Asset Management (Americas) LLC and multiple UBS AM affiliates as included in the disclosure and states accounts are managed on a discretionary basis with rights to dividends or sale proceeds. The filer certifies the holdings were acquired in the ordinary course of business and were not acquired to change or influence control of the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.72%
Tags
current report
-
Rhea-AI Summary

Thomas Schmidheiny and affiliated entities disclosed a significant 6.671% ownership stake in Amrize through a Schedule 13D filing. The position was acquired following Amrize's spin-off from Holcim on June 23, 2025.

Key ownership details:

  • Total beneficial ownership of 37,818,703 ordinary shares
  • Schweizerische Cement-Industrie-Aktiengesellschaft (SCIA) holds 37,111,376 shares (6.547%)
  • Cimcap AG holds 678,450 shares (0.120%)
  • Shares received as dividend-in-kind through Holcim's distribution

The spin-off separated Amrize's North American operations (US, Canada, Jamaica) from Holcim's global business. The reporting persons, all Swiss entities, have not disclosed specific plans regarding their investment but maintain the right to acquire additional shares or sell their position based on ongoing evaluation of business conditions and opportunities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Amrize (AMRZ) SEC filings are available on StockTitan?

StockTitan tracks 106 SEC filings for Amrize (AMRZ), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Amrize (AMRZ)?

The most recent SEC filing for Amrize (AMRZ) was filed on August 11, 2025.